Biogen
BIIB
BIIB
1,140 hedge funds and large institutions have $52.2B invested in Biogen in 2018 Q4 according to their latest regulatory filings, with 130 funds opening new positions, 374 increasing their positions, 452 reducing their positions, and 122 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,140
Holders Change
-4
Holders Change %
-0.35%
% of All Funds
25.44%
Holding in Top 10
29
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+3.57%
% of All Funds
0.65%
New
130
Increased
374
Reduced
452
Closed
122
Calls
$992M
Puts
$1.34B
Net Calls
-$347M
Net Calls Change
+$428M
Top Buyers
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
$1.1B |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
$661M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
$386M |
| 4 |
Invesco
Atlanta,
Georgia
|
$941M |
| 5 |
Goldman Sachs
New York
|
$542M |
